Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Canadian wildfire pollution associated with increased stroke severity

3

Mar 2026

Canadian wildfire pollution associated with increased stroke severity

Short-term surges in air pollution in New Jersey from the 2023 Canadian wildfires were associated with a higher stroke rate and more serious strokes, according to a preliminary study released March 3, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

Alcohol-warning labels and pricing could prevent cancer deaths

3

Mar 2026

Alcohol-warning labels and pricing could prevent cancer deaths

If Canadian jurisdictions mandated warning labels on alcohol and minimum pricing tied to the number of standard drinks in a container, it could prevent hundreds of cancer diagnoses and deaths, according to a new study led by University of Victoria's Canadian Institute for Substance Use Research (CISUR).

Seven hours sleep linked to lower insulin resistance risk

3

Mar 2026

Seven hours sleep linked to lower insulin resistance risk

Sleeping for 7 hours and 18 minutes every night may be the sweet spot for warding off the risk of insulin resistance-the precursor to type 2 diabetes-suggests a large observational study published in the open access journal BMJ Open Diabetes Research & Care.

Innovative peptide stapling system targets hard-to-treat cancers

3

Mar 2026

Innovative peptide stapling system targets hard-to-treat cancers

Researchers at the University of Bath have developed a new technology that uses bacteria to build, chemically stabilize, and test millions of potential drug molecules inside living cells, making it much quicker and easier to discover new treatments for difficult-to-treat cancers.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.